Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 3.88 at 9:45 am ET, low 3.77 at 1:00 pm ET.
the bull case· 4
3
of the funds on file reporting a position in LRMR
n-portas of Jun 30 '26162
managers reporting a position in thirteen f filings
13fJun 30 '26+13.81%
change in shares held by the ten largest reporting managers
13fJun 30 '262 of 23
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26the bear case· 3
15
managers whose positions together make up four fifths of reported value
13fJun 30 '260.01%
of iShares Russell two thousand ETF assets the largest fund weight on file
n-portJun 30 '267 of 7
recent reports where the move came in under the options implied range
earnings historyimplied vs realizedSides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 9 '26 report. Not a forecast, not advice.
Of the 6 companies Larimar Therapeutics, Inc. moves with most closely, none share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
162 managers report a position worth $294.6M between them, and 15 of them hold 80% of it.
tall tick = annual report · 1 on record
Larimar Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
LRMR (Larimar Therapeutics, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.